Pharma channel feed

San­doz wins FDA ap­proval for first two biosim­i­lars for Am­gen's block­buster bone drug

Last year
FDA+

UK's NICE rec­om­mends against cov­er­age for As­traZeneca and Dai­ichi's breast can­cer drug En­her­tu over cost-ef­fec­tive­ness

Last year

J&J ex­pands myelo­ma and health eq­ui­ty ef­forts with fe­male hip-hop pi­o­neer MC Lyte

Last year
Marketing

Mar­ket­ingRx roundup: Pfiz­er jumps on lat­est Tik­Tok trend; No­vo re­cruits for Ca­griSe­ma tri­al across lan­guages

Last year
Marketing

FDA de­nies hear­ing to Van­da on jet lag in­di­ca­tion for sleep dis­or­der drug

Last year
FDA+

Amy­lyx read­ies for make-or-break PhI­II, look­ing to ad­dress un­cer­tain­ty over con­tro­ver­sial ALS drug

Last year
R&D
In Focus

Bay­er on job cuts, pipeline gaps, obe­si­ty and Mon­san­to lit­i­ga­tion as ex­ecs de­fend keep­ing cur­rent struc­ture

Last year
R&D

Bay­er says no breakup ‘for now,’ fo­cus­es in­stead on fix­ing ‘bad­ly bro­ken’ ar­eas 

Last year

Re­pub­li­can sen­a­tors join at­tack on Biden's pro­pos­al to seize drug patents based on price

Last year
Law

FTC's Lina Khan and Mark Cuban head­line White House lis­ten­ing ses­sion to rail against PBMs

Last year

Hugel smooths out wrin­kles with FDA, wins ap­proval for Botox com­peti­tor

Last year
FDA+

San­doz com­pletes $170M buy of Lu­cen­tis biosim­i­lar from Co­herus Bio­Sciences

Last year
Deals

Q&A: Sanofi’s CEO on the con­sumer di­vesti­ture, a fu­ture in weight loss, an­titrust and AI’s se­cre­cy wave

Last year

Bay­er buys Eu­ro­pean rights to Bridge­Bio's AT­TR-CM pill

Last year
Deals

En­do inks $465M bank­rupt­cy deal set­tling crim­i­nal and civ­il opi­oid cas­es

Last year
Law

GAO di­rects ARPA-H to fi­nal­ize plan for han­dling du­pli­cate re­search

Last year
R&D
FDA+

ACIP rec­om­mends ex­pand­ed use for Val­neva's chikun­gun­ya vac­cine and Covid boost­ers

Last year

In­smed en­cour­ages peo­ple to 'S­peak Up' in new mar­ket­ing ef­fort

Last year
Marketing

UK re­lies on EMA's re­view of Xge­va re­for­mu­la­tion in first-ever rec­i­p­ro­cal ap­proval

Last year

Judge rules against As­traZeneca in suit over IRA price ne­go­ti­a­tions

Last year
Law

House com­mit­tee de­bates IRA changes that would im­pact or­phan drugs and oth­er ar­eas

Last year
FDA+

Phar­ma lags be­hind health­care in AI adop­tion, but many ex­pect wider use in next few years, study finds

Last year
Marketing

Bel­har­ra CEO talks the ins and outs of build­ing a biotech in a new pod­cast

Last year
Marketing

San­doz pays out $265M to set­tle part of an­titrust law­suit

Last year
Law
First page Previous page 67686970717273 Next page Last page
A service from the Financial Times